Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 6 28-6, 2003, Pages

  Balasubramaniam, Vivek ^a,c   Tang, Jen Ruey ^a   Maxey, Anne ^a   Plopper, Charles G ^b   Abman, Steven H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Angiogenesis; Congenital diaphragmatic hernia; Lung hypoplasia; Persistent pulmonary hypertension of the newborn; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE SYNTHASE; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; HETEROZYGOTE; HISTOPATHOLOGY; HYPOXIA; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG HYPOPLASIA; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WESTERN BLOTTING;

EID: 0037497941     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00421.2002     Document Type: Article

References (52)

1. Abman S. Pulmonary hypertension in chronic lung disease of infancy: pathogenesis, pathophysiology, and treatment. In: Chronic Lung Disease in Early Infancy, edited by Bland RD and Coalson JJ. New York: Dekker, 1999, p. 619-668.
2. Atkinson SA. Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. J Nutr 131: 942S-946S, 2001.
3. Aulakh CS, Wozniak KM, Hill JL, Devane CL, Tolliver TJ, and Murphy DL. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Neuroendocrinology 48: 401-406, 1988.
4. Baldwin HS. Early embryonic vascular development. Cardiovasc Res 31: E34-E45, 1996.
5. Bhatt AJ, Amin SB, Chess PR, Watkins RH, and Maniscalco WM. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 47: 606-613, 2000.
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
7. Burri P. Structural aspects of prenatal and postnatal development and growth for the lung. In: Lung Growth and Development, edited by McDonald JA. New York: Dekker, 1997, p. 1-35.
8. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, and Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159: 993-1008, 2001.
9. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
10. Coalson JJ, Winter VT, Siler-Khodr T, and Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160: 1333-1346, 1999.
11. Cooney TP and Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 2-intrauterine and early postnatal lung growth. Thorax 37: 580-583, 1982.
12. Dimmeler S, Dernbach E, and Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at Ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477: 258-262, 2000.
13. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280: C1358-C1366, 2001.
14. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, and Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604-2609, 2001.
15. Gebb SA and Shannon JM. Tissue interactions mediate early events in pulmonary vasculogenesis. Dev Dyn 217: 159-169, 2000.
16. Hefler LA, Reyes CA, O'Brien WE, and Gregg AR. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 64: 666-673, 2001.
17. Howard V and Reed MG. Unbiased Stereology: Three-Dimensional Measurement in Microscopy. Oxford, UK: Springer in association with the Royal Microscopical Society, 1998.
18. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
19. Husain AN, Siddiqui NH, and Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29: 710-717, 1998.
20. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, and Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
21. Jobe AH and Bancalari E. Bronchopulmonary dysplasia E. Am J Respir Crit Care Med 163: 1723-1729, 2001.
22. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641-643, 1999.
23. Kalenga M, Tschanz SA, and Burri PH. Protein deficiency and the growing rat lung. I. Nutritional findings and related lung volumes. Pediatr Res 37: 783-788, 1995.
24. Kalenga M, Tschanz SA, and Burri PH. Protein deficiency and the growing rat lung. II. Morphometric analysis and morphology. Pediatr Res 37: 789-795, 1995.
25. Kotecha S. Lung growth: implications for the newborn infant. Arch Dis Child Fetal Neonatal Ed 82: F69-F74, 2000.
26. Kroll J and Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998.
27. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, and Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164: 1981-1987, 2001.
28. Le Cras TD, Kim DH, Gebb S, Markham NE, Shannon JM, Tuder RM, and Abman SH. Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat. Am J Physiol Lung Cell Mol Physiol 277: L709-L718, 1999.
29. Le Cras TD, Kim DH, Markham NE, and Abman AS. Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude. Am J Physiol Lung Cell Mol Physiol 279: L283-L291, 2000.
30. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, and Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
31. Leuwerke SM, Kaza AK, Tribble CG, Kron IL, and Laubach VE. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol 282: L1272-L1278, 2002.
32. Margraf LR, Tomashefski JF Jr, Bruce MC, and Dahms BB. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 143: 391-400, 1991.
33. 2 alters postnatal development of lung alveoli. Am J Physiol Lung Cell Mol Physiol 257: L221-L225, 1989.
34. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
35. Mustonen T and Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895-898, 1995.
36. Neufeld G, Cohen T, Gengrinovitch S, and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
37. Northway WH Jr, Rosan RC, and Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357-368, 1967.
38. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, and Maragoudakis ME. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994.
39. Risau W. Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
40. Shannon J and Deterding R. Epithelial-mesenchymal interactions in lung development. In: Lung Growth and Development, edited by McDonald JA. New York: Dekker, 1997, p. 88-118.
41. Shen B, Lee DY, and Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274: 33057-33063, 1999.
42. Sobonya RE, Logvinoff MM, Taussig LM, and Theriault A. Morphometric analysis of the lung in prolonged bronchopulmonary dysplasia. Pediatr Res 16: 969-972, 1982.
43. Stelzner TJ, O'Brien RF, Yanagisawa M, Sakurai T, Sato K, Webb S, Zamora M, McMurtry IF, and Fisher JH. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 262: L614-L620, 1992.
44. Stocker JT, Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants. Hum Pathol 17: 943-961, 1986.
45. Tallquist MD, Soriano P, and Klinghoffer RA. Growth factor signaling pathways in vascular development. Oncogene 18: 7917-7932, 1999.
46. Tang JR, Le Cras TD, Morris KG Jr, and Abman SH. Brief perinatal hypoxia increases severity of pulmonary hypertension after reexposure to hypoxia in infant rats. Am J Physiol Lung Cell Mol Physiol 278: L356-L364, 2000.
47. Thurlbeck WM. The internal surface area of nonemphysematous lungs. Am Rev Respir Dis 95: 765-773, 1967.
48. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 95: 752-764, 1967.
49. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, and Abraham JA. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991.
50. Tschopp B and Weiss HJ. Decreased ATP, ADP and serotonin in young platelets of fawn-hooded rats with storage pool disease. Thromb Diath Haemorrh 32: 670-677, 1974.
51. Wang J, Morita I, Onodera M, and Murota S. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide, J Cell Physiol 190: 238-250, 2002.
52. Zamora MR, Stelzner TJ, Webb S, Panos RJ, Ruff LJ, and Dempsey EC. Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol Lung Cell Mol Physiol 270: L101-L109, 1996.